Sunstar Suisse takes over Degradable Solutions, a Spin-Off Company of the ETH
Sunstar Suisse, a company of the Sunstar Group, one of the world’s leading healthcare companies with its head office in Etoy, is taking over Degradable Solutions, a spin-off of the Federal Institute of Technology Zurich (ETH), with a head office in Schlieren. This gives Sunstar access to the cutting-edge technology and the market-proven products of Degradable Solutions. In pursuit of its strategic goal of becoming a total-oral-health company, Sunstar is expanding its research and business activities from prevention to therapy with this acquisition. The founder of Degradable Solutions remains the CEO of the company. All jobs and activities are also taken over.
The privately-owned Sunstar Group, one of the world’s ten largest companies in the field of mouth and body care, is today announcing the complete takeover of Degradable Solutions. Sunstar Suisse has taken over all the shares of the company, a spin-off of the Federal Institute of Technology Zurich (ETH), from the previous private owners. Dr Kurt Ruffieux, the founder and CEO of Degradable Solutions, will from now on manage the company as an autonomous business unit of Sunstar. The entire organisation with more than 25 staff, and all activities at the headquarters in Schlieren near Zurich, are also being taken over. At the same time, Masakazu Nakamura, CEO of Sunstar Suisse, and Cyril Alemany, Director New Business Development of Sunstar Suisse, are joining the Board of Directors of Degradable Solutions. The parties have agreed not to divulge any details about the transfer price.
With this takeover, Sunstar is significantly expanding the technology sector of regenerative medical products. This core competence of Degradable Solutions involves products that have a temporary function in the body and then degrade automatically. Examples are resorbable bone fixation implants which stabilise a bone fracture for several weeks, or implants that temporarily support tissue regeneration. In many instances, this technology simplifies the therapy and reduces the need for additional surgery to remove the implantation. The company attracted attention with the injectable bone regeneration material easy-graft, which rapidly advanced to third place in the European dental market. The two partners intend to bring together existing designs under the umbrella brand of GUIDOR, develop new pioneering therapies and products, and thus gain a leading position in the market.
Masakazu Nakamura, CEO of Sunstar Suisse, comments; "With Degradable Solutions, we are broadening our worldwide technology network by adding a unique gem. As a spin-off of the internationally renowned ETH, Degradable Solutions is much more than a promising start-up company. With products that have already been successfully launched on the market, and a complete value creation chain from research via development and production to marketing, Degradable Solutions is excellently positioned in a rapidly growing market with high margins. This acquisition takes us closer to the vision of positioning Sunstar as a total-oral-health-company. With the internationally patented and certified know-how of Degradable Solutions, we can take the vital step of expanding our products and services from prevention to therapy. Finally, I am particularly gratified that we were able to secure the support for Sunstar of Dr Kurt Ruffieux who, as a renowned researcher and entrepreneur, will continue to develop Degradable Solutions. This acquisition thus brings added strategic, operational and personnel value to our global activities."
Dr Kurt Ruffieux, the founder and CEO of Degradable Solutions, adds; "Today is an important day in the his-tory of our company. With the globally active Sunstar, we have found the best partner for the next phase in our growth. Not only do we work in the same field of medicine, and our technology and product ranges supplement each other perfectly, we also share the same philosophy. As focused private companies, we both have a commitment to research and development, and the conviction that continuous innovation is capable of steadily improving both the well-being of patients as well as cost-effectiveness in the healthcare field. Our staff and I look forward to the future of Degradable Solutions as part of the Sunstar Group."